World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 5 September 2022
Main ID:  ACTRN12618000879268
Date of registration: 25/05/2018
Prospective Registration: Yes
Primary sponsor: University of Sydney
Public title: Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on Outcome (TORPIDO 30/60)
Scientific title: Lower or higher initial oxygen concentration with Targeted Oxygen saturation in Respiratory care of premature Infants at Delivery: effects on Outcome (TORPIDO 30/60)
Date of first enrolment: 13/09/2018
Target sample size: 1470
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12618000879268.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Phase 3
Countries of recruitment
Australia India Malaysia Singapore Spain United States of America
Contacts
Name: Dr Ju-Lee Oei   
Address:  Neonatal Intensive Care Unit Royal Hospital for Women Randwick, NSW 2031 Australia
Telephone: +61 2 9382 6152
Email: j.oei@unsw.edu.au
Affiliation: 
Name: Ms Trial Coordinator   
Address:  c/o TORPIDO30/60 Coordinator Locked Bag 77 Camperdown NSW 1450 Australia
Telephone: +61 2 9562 5000
Email: torpido3060.study@sydney.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Premature infants born from 23/0 to 28/6 weeks gestation
Exclusion criteria: Any known major cardiopulmonary abnormalities that could affect oxygenation or congenital malformations that could affect neuro-developmental outcome or survival

Age minimum: 23 Weeks
Age maximum: 29 Weeks
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Premature infants requiring resuscitation at birth;
Premature infants requiring resuscitation at birth
Reproductive Health and Childbirth - Complications of newborn
Intervention(s)
At delivery, a CPAP mask will be applied by the caregiver (e.g. midwife, neonatal clinician, obstetrician, anaesthetist), and initial FiO2 level will be set to 0.6. Using a pulse oximeter, FiO2 will be adjusted as required to achieve target SpO2 (80-85% at 5 min and 85-95% at 10 min and thereafter), until admission to the NICU.
Primary Outcome(s)
The composite primary outcome comprises survival free from major brain injury (assessed by routine ultrasound or other imaging and/or clinical assessment). Brain injury is defined as periventricular haemorrhage (on either side of the head) seen on ultrasound with grade 1-4, or the presence by ultrasound after 14 days of any of the following: echodense
intraparenchymal lesions, periventricular leukomalacia (PVL) or porencephalic cysts[To 36 weeks gestation]
Secondary Outcome(s)
Tertiary Outcome (Hypothesis Generating) - Number of infants with Patent ductus arteriosus (PDA) will be collected from hospital records. [From birth until discharge home]
Tertiary Outcome (Hypothesis Generating) - Number of infants with necrotising enterocolitis (NEC) confirmed with radiolographs, associated with surgery or death.[From birth until discharge home]
Tertiary Outcome (Hypothesis Generating) - Number of infants with severe retinopathy of prematurity (ROP) as assessed by an ophthalmologist in the neonatal unit.[From birth until discharge home]
Tertiary Outcome (Hypothesis Generating) - Survival without major disability at 2-3 years corrected for gestation. Disability will be assessed by one or more of the following assessments:
a) The Bayley Scales of Infant Development (BSID);
b) The Ages and Stages Questionnaire (ASQ);
c) Short Health Status Questionnaire (SHQ)
The ASQ and SHQ will be collected for all participants, and the BSID will be collected where routinely done.[at 24-36 months corrected age.]
Tertiary Outcome (Hypothesis Generating) - Measured (by pulse oximeter) in 1 minute increments for the first 10 minutes of life and every 5 minutes thereafter until admission to NICU, the time it takes to reach SpO2 greater or equal to 80%[From birth until SpO2 reaches 80%]
Tertiary Outcome (Hypothesis Generating) - Duration of hospital stay defined as the number of days from admission to final discharge home (taken from hospital records). [From birth until discharge home]
All-cause mortality (from hospital records)[Death occurring on any day between birth and discharge home. ]
Tertiary Outcome (Hypothesis Generating) - Endotracheal Intubation in delivery suite required due to depressed respiratory effort (taken from hospital records).[From birth until admission to NICU]
Tertiary Outcome (Hypothesis Generating) - Heart rate at each minute for the first 10 minutes after birth and then every 5 minutes until admission to NICU will be taken from hospital records.[From birth until admission to NICU]
Tertiary Outcome (Hypothesis Generating) - Number of infants with Broncho-pulmonary dysplasia (BPD) defined as requirement for supplemental oxygen or respiratory support survival to 36 weeks, collected from hospital records.[36 weeks gestation.]
Major brain injury from any imaging performed before discharge home. Brain injury is defined as periventricular haemorrhage (on either side of the head) seen on ultrasound with grade 1-4, or the presence by ultrasound after 14 days of any of the following: echodense intraparenchymal lesions, periventricular leukomalacia (PVL) or porencephalic cysts[From any imaging performed before discharge home.]
Tertiary Outcome (Hypothesis Generating) - Number of infants with late onset sepsis will be collected from hospital records.[From 48 hours of life until discharge home]
Tertiary Outcome (Hypothesis Generating) - Apgar scores (a summary of the health of the newbown) at 1 and 5 minutes[At 1 and 5 minutes of life]
Tertiary Outcome (Hypothesis Generating) - Number of infants with severe periventricular haemorrhage from any imaging performed before discharge home. [From birth until discharge home]
Tertiary Outcome (Hypothesis Generating) - Oxygen saturation (SpO2) will be monitored using a pulse oximeter until admission to NICU[From birth until admission to NICU]
Secondary ID(s)
Nil
Source(s) of Monetary Support
National Health and Medical Research Council
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 12/06/2018
Contact:
Hunter New England Local Health Distritct
Status: Approved
Approval date: 02/01/2020
Contact:
HREC of the Northern Territory Department of Health and Menzies School of Health Research
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history